All doses of Novo Nordisk’s blockbuster diabetes and obesity drugs were listed as available on the FDA shortage list as of ...

Among the list of drugs in development for Alzheimer's compiled by Phrma, there is an interesting proposal, the protease ...

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

"We are honored to be recognized by BioSpace as one of the Best Places to Work in 2025,” said Richard J. Daly, President and Chief Executive Officer. "Our goal has always been to create an environment ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

Cyclacel Pharmaceuticals, Inc. (CYCC) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $7.35 per share a year ago.

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

ANIP may be acquired soon with a potential offer exceeding $8 billion and contingent on FDA approval of a new drug filed in ...

Australia’s audit office will probe the Morrison government’s $2 billion deal with US pharmaceutical giant Moderna to set up ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A ...